Ping Wei - Search Results

Year	Number of Results
2001	1
2003	1
2007	2
2008	3
2009	1
2011	2
2012	1
2013	3
2014	6
2015	4
2017	7
2018	6
2019	4
2020	5
2021	6

1

Ping wei san, a Chinese medicine for gastrointestinal disorders.

Riedlinger JE, Tan PW, Lu W. Riedlinger JE, et al. Ann Pharmacother. 2001 Feb;35(2):228-35. doi: 10.1345/aph.10122. Ann Pharmacother. 2001. PMID: 11215844 Review.

OBJECTIVE: To describe the dilemma that American pharmacists face when their patient uses a traditional Chinese herbal formula. Ping wei san (PWS), an agent used to treat gastrointestinal disorders, is used to illustrate the problems encountered and to identify reso …

OBJECTIVE: To describe the dilemma that American pharmacists face when their patient uses a traditional Chinese herbal formula. Ping …

2

Non-invasive diagnosis of early-stage lung cancer using high-throughput targeted DNA methylation sequencing of circulating tumor DNA (ctDNA).

Liang W, Zhao Y, Huang W, Gao Y, Xu W, Tao J, Yang M, Li L, Ping W, Shen H, Fu X, Chen Z, Laird PW, Cai X, Fan JB, He J. Liang W, et al. Theranostics. 2019 Apr 6;9(7):2056-2070. doi: 10.7150/thno.28119. eCollection 2019. Theranostics. 2019. PMID: 31037156 Free PMC article.

3

Clinical and Transmission Characteristics of Covid-19 - A Retrospective Study of 25 Cases from a Single Thoracic Surgery Department.

Li YK, Peng S, Li LQ, Wang Q, Ping W, Zhang N, Fu XN. Li YK, et al. Curr Med Sci. 2020 Apr;40(2):295-300. doi: 10.1007/s11596-020-2176-2. Epub 2020 Mar 30. Curr Med Sci. 2020. PMID: 32232652 Free PMC article.

4

Coronavirus Disease 2019 in the Perioperative Period of Lung Resection: A Brief Report From a Single Thoracic Surgery Department in Wuhan, People's Republic of China.

Cai Y, Hao Z, Gao Y, Ping W, Wang Q, Peng S, Zhao B, Sun W, Zhu M, Li K, Han Y, Kuang D, Chu Q, Fu X, Zhang N. Cai Y, et al. J Thorac Oncol. 2020 Jun;15(6):1065-1072. doi: 10.1016/j.jtho.2020.04.003. Epub 2020 Apr 11. J Thorac Oncol. 2020. PMID: 32289516 Free PMC article.

5

Integrated Chinese Herbal Medicine and Western Medicine on the Survival in Patients with Colorectal Cancer: A Retrospective Study of Medical Records.

Yeh MH, Chiu HP, Wu MC, Koo M, Lin NW, Liao KK, Yeh CC, Li TM. Yeh MH, et al. Evid Based Complement Alternat Med. 2020 Jan 13;2020:4561040. doi: 10.1155/2020/4561040. eCollection 2020. Evid Based Complement Alternat Med. 2020. PMID: 32089722 Free PMC article.

Results from multivariate Cox regression analysis showed that CHM use was significantly associated with better survival (adjusted hazard ratio = 0.54, 95% CI = 0.38 to 0.77). In addition, the CHM formulae Jia Wei Xiao Yao San, Zhi Bah Di Huang Wan, Ping Wei S …

Results from multivariate Cox regression analysis showed that CHM use was significantly associated with better survival (adjusted hazard rat …

6

Surgical outcomes of segmental bronchial sleeve resection in central non-small cell lung cancer.

Qu R, Ping W, Hao Z, Cai Y, Zhang N, Fu X. Qu R, et al. Thorac Cancer. 2020 May;11(5):1319-1325. doi: 10.1111/1759-7714.13403. Epub 2020 Mar 21. Thorac Cancer. 2020. PMID: 32198981 Free PMC article.

7

Modified McKeown procedure with uniportal thoracoscope for upper or middle esophageal cancer: initial experience and preliminary results.

Wang Q, Ping W, Cai Y, Fu S, Fu X, Zhang N. Wang Q, et al. J Thorac Dis. 2019 Nov;11(11):4501-4506. doi: 10.21037/jtd.2019.11.07. J Thorac Dis. 2019. PMID: 31903238 Free PMC article.

8

[Advance of circulating tumor cell in patients with lung cancer].

Ping W, Fu X. Ping W, et al. Zhongguo Fei Ai Za Zhi. 2011 Jun;14(6):543-6. doi: 10.3779/j.issn.1009-3419.2011.06.12. Zhongguo Fei Ai Za Zhi. 2011. PMID: 21645461 Free PMC article. Review. Chinese. No abstract available.

9

[Recurrent respiratory infection in children treated with assistant of Ping-Wei powders--report of 45 cases].

Hu SP. Hu SP. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2008 Jan;28(1):85-6. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2008. PMID: 18928023 Chinese. No abstract available.

10

Combining CDK4/6 inhibition with taxanes enhances anti-tumor efficacy by sustained impairment of pRB-E2F pathways in squamous cell lung cancer.

Cao J, Zhu Z, Wang H, Nichols TC, Lui GYL, Deng S, Rejto PA, VanArsdale T, Hardwick JS, Weinrich SL, Wei P. Cao J, et al. Oncogene. 2019 May;38(21):4125-4141. doi: 10.1038/s41388-019-0708-7. Epub 2019 Jan 30. Oncogene. 2019. PMID: 30700828

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results